Track Ingevity Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ingevity Corporation NGVT · Stock Open Ingevity Corporation in new tab

61.72 USD
P/E
58.78
EPS
1.05
P/B
33.27
ROE
35.31
Beta
1.11
Target Price
88.67 USD
Ingevity Corporation logo

Ingevity Corporation

🧾 Earnings Recap – Q3 2025

Ingevity's Q3 2025 results showcased strong execution, with significant strategic milestones, including the announcement of the $110 million sale of its Industrial Specialties business and an impressive 33% EBITDA margin, marking a sixth consecutive quarter of margin expansion.

  • Total sales decreased by 4% to $362 million, driven by declines in Industrial Specialties and APT, despite growth in Performance Materials and Road Technologies.
  • Adjusted EBITDA reached $56.3 million, up nearly 500 basis points, resulting in an EBITDA margin of 33.5%.
  • Strong free cash flow of $118 million enabled $25 million in share repurchases and ahead-of-target debt reduction, bringing net leverage down to 2.7x.
  • Performance Materials displayed volume growth with 3% sales increase, while APT faced continued pressure from tariffs and competitive dynamics, anticipating a mid-teen revenue decline for the full year.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 24, 2027
P/E58.78
EPS1.05
Book Value1.86
Price to Book33.27
Debt/Equity1871.75
% Insiders1.183%
Growth
Revenue Growth-0.08%
Earnings Growth0.20%
Estimates
Forward P/E10.35
Forward EPS5.96
Target Mean Price88.67

DCF valuation

Model fair value for Ingevity Corporation (NGVT)
Result
Sign in to run the valuation for NGVT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
3 analysts · consensus Strong buy · mean target 88.67 USD (low 85.00, high 95.00) · as of 14 Nov 2026
Low 85.00
Mean 88.67
High 95.00
Price 61.72
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Ingevity Corporation Logo Ingevity Corporation Analysis (NGVT)

United States Materials Official Website Stock

Is Ingevity Corporation a good investment? Ingevity Corporation (NGVT) is currently trading at 61.72 USD. Market analysts have a consensus price target of 88.67 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 58.78. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Ingevity Corporation is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 5.96.

Investor FAQ

Does Ingevity Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Ingevity Corporation?

Ingevity Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of 1.05.

Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Exchange Ticker
NYQ (United States) NGVT
FRA (Germany) IGX.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion